Rituximab Intravenous and Simvastatin and niacin

• Generic Name: rituximab
• Dosage Forms: n.a.
• Other Brand Names: Rituxan, Truxima

Rituximab injection is used alone or together with other medicines to treat a type of cancer called non-Hodgkin's lymphoma (NHL). It helps the immune system destroy cancer cells. Rituximab injection is a monoclonal antibody.

Rituximab injection is used together with other medicines (eg, fludarabine cyclophosphamide) to treat chronic lymphocytic leukemia (CLL).

Rituximab injection is used together with methotrexate to treat the symptoms of rheumatoid arthritis. It helps to keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, or infliximab) did not work well.

Rituximab injection is used together with steroids to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). These are immune disorders that cause blood vessels to be inflamed.

Rituximab injection is also used to treat moderate to severe pemphigus vulgaris (PV), an immune disorder that causes painful blisters on the skin and mucous membranes.

Rituximab is to be administered only by or under the direct supervision of your doctor.

• Generic Name: niacin / simvastatin
• Dosage Forms: n.a.
• Other Brand Names: Simcor

Simvastatin and niacin combination is used together with a proper diet to lower cholesterol and triglyceride (fat) levels in the blood. Simvastatin and niacin may help prevent medical problems caused by clogged blood vessels, such as heart attacks and strokes.

Simvastatin and niacin work together to treat cholesterol and lipid (fat) disorders. Niacin is vitamin B3, which reduces the amount of cholesterol in the blood. Simvastatin belongs to the group of medicines called HMG-CoA inhibitors or statins. It works to reduce the amount of cholesterol in the blood by blocking an enzyme that is needed to make cholesterol.

Simvastatin and niacin was available only with your doctor's prescription. The Simcor(R) product will no longer be marketed in the United States as of April 18, 2016.